NCT05456061View on ClinicalTrials.gov

Effect of ADDE on Tear Interferometry

NACompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

August 1, 2019

Study Completion Date

January 31, 2022

Conditions
TearDry Eye Syndromes
Interventions
DRUG

3% diquafosol eyedrops

Diquas® (Santen, Osaka, Japan), six times per day.

PROCEDURE

Silicone punctal plug insertion

a silicone punctal occluder (Parasol® Punctal Occluder, BVI, Waltham, Massachusetts, USA), inserted into the lower eyelid

Trial Locations (1)

03722

Severance Hospital, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT05456061 - Effect of ADDE on Tear Interferometry | Biotech Hunter | Biotech Hunter